0R15 9025.0 0.0% 0R1E 9410.0 0.0% 0M69 None None% 0R2V 247.99 9682.643% 0QYR 1567.5 0.0% 0QYP 439.3701 -2.9016% 0RUK None None% 0RYA 1597.0 1.2682% 0RIH 195.55 0.0% 0RIH 191.4 -2.1222% 0R1O 225.5 9683.0803% 0R1O None None% 0QFP 10475.8496 107.8542% 0M2Z 252.573 0.2373% 0VSO 33.0 -7.3164% 0R1I None None% 0QZI 622.0 0.0% 0QZ0 220.0 0.0% 0NZF None None% 0YXG 222.05 -4.1318%

CompuGroup Medical AG O.N.

GB 0MSD

21.6472GBP
5.43(33.46%)

Last update at 2024-12-18T08:00:00Z

Day Range

21.6221.80
LowHigh

52 Week Range

32.9452.05
LowHigh

Fundamentals

  • Previous Close 16.22
  • Market Cap19.90M
  • Volume10475
  • P/E Ratio0.28
  • Dividend Yield1.23%
  • EBITDA192.45M
  • Revenue TTM1247.10M
  • Revenue Per Share TTM23.88
  • Gross Profit TTM 411.71M
  • Diluted EPS TTM1.44

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 106.82M 97.87M 110.43M 107.75M 134.10M
Minority interest - - 0.27M 0.81M 2.11M
Net income 73.41M 68.97M 73.19M 65.82M 96.08M
Selling general administrative - - 8.61M 10.13M 6.82M
Selling and marketing expenses - - - - -
Gross profit 411.71M 373.55M 335.98M 292.03M 302.69M
Reconciled depreciation - - - - -
Ebit 94.49M 106.63M 120.19M 115.95M 141.65M
Ebitda 147.69M 160.91M 158.65M 144.02M -
Depreciation and amortization 53.20M 54.28M 38.46M 28.07M -
Non operating income net other - - - - -
Operating income 94.49M 106.63M 120.19M 115.95M 143.23M
Other operating expenses 1059.68M 960.15M 755.01M 658.05M 100.66M
Interest expense - 0.00000M 0.00000M 0.00000M 0.00000M
Tax provision - - 37.01M 41.59M 37.76M
Interest income - - 9.95M 5.04M 10.47M
Net interest income - - - - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 32.70M 28.84M 37.01M 41.59M 37.76M
Total revenue 1174.81M 1062.70M 869.21M 770.43M 717.02M
Total operating expenses 296.58M 271.00M 221.78M 179.66M -
Cost of revenue 763.10M 689.15M 533.23M 478.40M 414.33M
Total other income expense net 12.33M -8.75300M -9.76000M -8.20400M -
Discontinued operations - - - - -
Net income from continuing ops - - - - -
Net income applicable to common shares 73.41M 68.97M 73.19M 65.82M 96.08M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 1944.44M 1790.81M 1565.77M 1065.86M 848.31M
Intangible assets 651.67M 622.95M 543.29M 336.13M 274.33M
Earning assets - - - - -
Other current assets 78.90M 60.01M 43.58M 39.05M 5.38M
Total liab 1270.62M 1178.53M 926.84M 805.95M 586.59M
Total stockholder equity 672.42M 612.07M 638.67M 259.11M 261.72M
Deferred long term liab 1.20M 1.20M 1.20M 1.20M 1.20M
Other current liab 266.34M 305.15M 226.01M 189.21M 67.87M
Common stock 53.73M 53.73M 53.73M 53.22M 53.22M
Capital stock - - - - -
Retained earnings - - 611.26M 310.71M 273.07M
Other liab 161.98M 154.56M 138.11M 116.70M 80.51M
Good will 639.16M 588.41M 542.45M 330.90M 262.21M
Other assets 24.89M 35.48M 32.99M 32.24M 30.27M
Cash 90.52M 107.34M 75.91M 46.35M 19.63M
Cash and equivalents - - - - -
Total current liabilities 375.47M 398.35M 290.54M 236.30M 184.29M
Current deferred revenue - - - - -
Net debt -90.51700M -107.34300M -75.91000M -46.35000M -
Short term debt - - 4.47M 4.41M 0.60M
Short long term debt - - - - -
Short long term debt total - - 498.19M 452.94M 318.85M
Other stockholder equity 618.68M 558.34M 584.93M 205.89M 253.76M
Property plant equipment 160.89M 158.00M 136.29M 131.25M 83.65M
Total current assets 420.81M 370.78M 308.11M 232.93M 192.81M
Long term investments - - - - -
Net tangible assets -618.41700M -599.28500M -447.07300M -407.93300M -269.42100M
Short term investments 0.07M 0.23M 0.12M 0.15M 2.62M
Net receivables 221.87M 182.55M 170.35M 119.88M 131.40M
Long term debt - - 470.20M 424.45M 302.60M
Inventory 29.44M 20.64M 18.16M 27.49M 19.58M
Accounts payable 109.14M 93.19M 64.52M 47.09M 39.29M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - -86.32200M -45.25900M
Accumulated amortization - - - - -
Non currrent assets other -1498.74400M -1384.55900M -1224.67200M -800.68700M -
Deferred long term asset charges - - - - -
Non current assets total 1498.74M 1384.56M 1224.67M 800.69M -
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -4.63100M -6.05300M -2.02700M -2.02700M -2.02700M
Change to liabilities 5.19M 30.57M 7.32M 2.45M -7.83800M
Total cashflows from investing activities -145.41400M -163.97600M -457.11600M -139.44400M -47.48000M
Net borrowings 19.06M 152.79M 24.85M 117.92M -50.90700M
Total cash from financing activities -16.35900M 30.15M 338.07M 49.68M -93.41000M
Change to operating activities 7.01M -2.19700M 2.79M -16.82900M 6.49M
Net income 73.41M 68.97M 73.19M 65.82M 96.08M
Change in cash -16.82600M 31.43M 29.56M 21.05M -5.06000M
Begin period cash flow 107.34M 75.91M 46.35M 25.30M -
End period cash flow 90.52M 107.34M 75.91M 46.35M 25.30M
Total cash from operating activities 145.03M 165.27M 149.93M 110.50M 136.35M
Issuance of capital stock - - - - -
Depreciation 78.93M 75.83M 55.59M 44.67M 26.07M
Other cashflows from investing activities - - -401.38700M -95.70400M -7.12700M
Dividends paid 26.12M 26.37M 24.21M 24.41M 17.40M
Change to inventory -8.78800M -2.28000M 9.49M -6.23700M -7.07100M
Change to account receivables -28.76100M -7.70300M -34.82300M 6.62M -4.62100M
Sale purchase of stock -9.10900M -96.09600M 337.99M -41.06300M -24.96700M
Other cashflows from financing activities 339.81M 264.90M 826.47M 185.73M -0.13300M
Change to netincome 2.81M -12.63300M 13.14M 7.14M 13.75M
Capital expenditures 25.85M 27.05M 17.68M 14.68M 12.73M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -37.54900M -9.98300M -25.32900M 0.38M -15.21700M
Stock based compensation 2.64M 5.72M 5.88M 3.90M -
Other non cash items 27.59M 24.74M 40.59M -4.27700M -
Free cash flow 119.18M 138.22M 132.25M 95.81M -

Peer Comparison

Sector: Industry:

Company Change (GBP) Price (GBP) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x)
0MSD
CompuGroup Medical AG O.N.
5.43 33.46% 21.65 0.28 - 0.02 -
0RIH
Alphabet Inc Class A
- -% 195.55 - - - -
0QFP
Gedeon Richter PLC
5435.85 107.85% 10475.85 - - - -
0M2Z
Equinor ASA
0.60 0.24% 252.57 - - - -
0VSO
BYD Co. Ltd.
-2.605 7.32% 33.00 - - - -

Reports Covered

Stock Research & News

Profile

CompuGroup Medical SE & Co. KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. The company's Ambulatory Information Systems segment develop and sell practice management software for registered physicians, medical care centers, and physician networks; and offers supplementary internet and intranet solutions. Its Pharmacy Information Systems segment develop and sell administrative and billing related software applications, which includes procuring and shipping, managing and controlling inventory, planning, performing, and monitoring retail activities for pharmacies. Hospital Information Systems segment develop and sells of clinical and administrative solutions for inpatient sector; healthcare services to acute care hospitals, rehabilitation centers, welfare institutions, multi-location hospital networks, healthcare regions, regional care organizations, medical laboratories, and radiologists. The Consumer & Health Management Information Systems segment provides software interfaces for data exchange, portals for retrieving data from the German outpatient healthcare market, medical decision support tools, medication and treatment databases for healthcare service providers, solutions for the insurance industry, and digital healthcare applications, consumer portals, and mobile apps; and operates telematics infrastructure business, which offers secure links, as well as security solutions for service providers. The company was founded in 1987 and is headquartered in Koblenz, Germany.

CompuGroup Medical AG O.N.

Maria Trost 21, Koblenz, Germany, 56070

Key Executives

Name Title Year Born
Mr. Michael Rauch L.L.M., M.B.A. CFO, MD & Member of Management Board 1972
Mr. Hannes Reichl MD of Impatient & Social Care and Member of the Management Board 1976
Dr. Eckart Pech MD of Consumer & Health Management Information Systems and Member of the Management Board 1969
Mr. Emanuele Mugnani MD of Ambulatory Information Systems Europe & Member of Management Board 1970
Ms. Angela Mazza Teufer MD of Ambulatory Information Systems DACH, Connectivity & CLICKDOC & Member of Management Board 1973
Ms. Claudia Thomé Corp. VP of Investor Relations 1971
Alexander Weimer Head of Corp. & Co-Head of Brand Communications NA
Mr. Oliver Bruzek Chief Communication Officer of Political & Public Affairs NA
Michael Franz Co- Head of Brand Communication NA
Mr. Helge Weiß Sr. VP of Connectivity NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions